Transparancy information: Devgen nv
(Thomson Reuters ONE) -
Regulated information
Zwijnaarde - April 8, 2010
In accordance with Article 15 §1 of the Act of May 2, 2007 on the disclosure of
major shareholdings, Devgen nv hereby announces the following data:
Information as of April 7, 2010:
Basic data
+-----------------------------------------------------------------+------------+
|Total share capital (EUR) |1,475,155.87|
+-----------------------------------------------------------------+------------+
|Total number of securities conferring voting rights | 19,668,776 |
+-----------------------------------------------------------------+------------+
|Total number of voting rights (the denominator): | 19,668,776 |
+-----------------------------------------------------------------+------------+
|Total number of securities conferring voting rights by category: | N/A |
+-----------------------------------------------------------------+------------+
|Total number of voting rights by category | N/A |
+-----------------------------------------------------------------+------------+
Additional facts
+--------------------------------------------------------------------+---------+
|Total number of convertible bonds conferring voting rights | none |
+--------------------------------------------------------------------+---------+
|Total number of rights, materialized by certificates or not, to |1,555,238|
|subscribe to not yet issued securities which confer voting rights |warrants |
+--------------------------------------------------------------------+---------+
|Total number of voting rights which result from the exercise of |1,555,238|
|these conversion or subscription rights | |
+--------------------------------------------------------------------+---------+
|Total number of shares without voting rights | none |
+--------------------------------------------------------------------+---------+
About Devgen nv
Devgen's mission is to enable farmers to sustainably grow more food on less
land, with less water, agrochemicals and labour.
Devgen uses advanced biotechnology and molecular breeding technology to make
high yielding seeds and crop protection solutions with a superior environmental
profile.
Devgen brings this technology to the market in the world's major food and feed
crops through two complementary strategies:
- Licensing Devgen technology for use in corn, cotton and soy and selected
other crops in exchange for R&D funding, and milestone and royalty payments.
- Producing and selling its premium hybrid seeds in major field crops such as
rice, sunflower, sorghum, and pearl millet, in the Indian subcontinent and
South-East Asia.
In its Crop Protection unit, Devgen developed and has taken to market a novel
nematicide, an agro-chemical product that protects crops from damage by
parasitic nematodes.
Incorporated in 1997, Devgen has offices in Ghent (Belgium), Singapore,
Hyderabad (India), General Santos (Phillippines) and Delaware (US) and employs
close to 280 people.
For more information please contact:
Thierry Bogaert, Wim Goemaere, CFO
CEO
Tel. +32 9 324 24 24 Tel. +32 9 324 24 24
Thierry.Bogaert(at)devgen.com Wim.Goemaere(at)devgen.com
Or visit: www.devgen.com
This press release may contain forward-looking statements containing the words
"anticipates", "expects" , "intends", "plans", "estimates", "may" and
"continues" as well as similar expressions. Such forward looking statements may
involve known and unknown risks, uncertainties and other factors which might
cause the actual results, performance or achievements of Devgen to be materially
different from any future results or achievements expressed or implied by such
forward-looking statements. Factors that could cause or contribute to such
differences include, among others: agricultural risks and difficulties,
including weather factors, diseases and pests, the costs and requirements of
regulatory compliance and the speed with which approvals are received; public
acceptance of biotechnology products; political, economic and social
developments in countries where Devgen operates and other risks and factors
detailed in the company's most recent annual report.
These forward looking statements speak only as of the date of publication of
this document. Devgen disclaims any obligation to update such forward looking
statements in this document to reflect any change in its expectations,
conditions or circumstances on which such statement is based, unless required by
law or regulation. This document does not constitute, or form part of, any offer
or invitation to sell or issue, or any solicitation of any offer, to purchase or
subscribe for any securities issued by Devgen NV.
[HUG#1401578]
PR ENG FINAL: http://hugin.info/135721/R/1401578/356569.pdf
Unternehmensinformation / Kurzprofil:
Datum: 08.04.2010 - 20:00 Uhr
Sprache: Deutsch
News-ID 18755
Anzahl Zeichen: 0
contact information:
Town:
Gent-Zwijnaarde
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 218 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Transparancy information: Devgen nv"
steht unter der journalistisch-redaktionellen Verantwortung von
Devgen (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
